Nathan Weinstein
Stock Analyst at Aegis Capital
(0.27)
# 3,663
Out of 4,667 analysts
63
Total ratings
17.31%
Success rate
-18.12%
Average return
Main Sectors:
Stocks Rated by Nathan Weinstein
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| EVGN Evogene | Maintains: Buy | $100 → $80 | $1.65 | +4,748.48% | 2 | Sep 12, 2022 | |
| DRIO DarioHealth | Maintains: Buy | $20 → $15 | $0.78 | +1,823.08% | 6 | Aug 18, 2022 | |
| VNRX VolitionRx | Maintains: Buy | $9 → $6 | $0.81 | +640.74% | 5 | Aug 15, 2022 | |
| IMUX Immunic | Maintains: Buy | $40 → $35 | $1.07 | +3,171.03% | 2 | Aug 8, 2022 | |
| STXS Stereotaxis | Initiates: Buy | $6 | $2.03 | +195.57% | 1 | Jul 12, 2022 | |
| ORMP Oramed Pharmaceuticals | Maintains: Buy | $35 → $30 | $2.26 | +1,227.43% | 5 | May 16, 2022 | |
| TRVI Trevi Therapeutics | Initiates: Buy | $10 | $2.77 | +261.01% | 1 | Mar 29, 2022 | |
| MDWD MediWound | Maintains: Buy | $63 → $49 | $16.78 | +192.01% | 4 | Mar 21, 2022 | |
| ENVB Enveric Biosciences | Downgrades: Hold | $350 → $10 | $0.35 | +2,757.96% | 2 | Mar 8, 2022 | |
| CING Cingulate | Initiates: Buy | $2,160 | $4.48 | +48,114.29% | 1 | Jan 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $30 | $1.64 | +1,729.27% | 1 | Dec 7, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $750 → $600 | $0.75 | +79,454.49% | 2 | Nov 15, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $9 → $10 | $1.32 | +657.58% | 2 | Nov 1, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $180 → $160 | $15.12 | +958.20% | 2 | Sep 22, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $60 → $56 | $30.02 | +86.54% | 2 | Sep 9, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $26 → $27 | $1.59 | +1,598.11% | 3 | Aug 17, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $40 → $35 | $1.18 | +2,866.10% | 4 | Jun 7, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $12 | $1.55 | +674.19% | 1 | Mar 22, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $75 | $12.85 | +483.66% | 1 | Jan 26, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $13 → $11 | $0.32 | +3,291.92% | 3 | Oct 19, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $180 | $2.61 | +6,796.55% | 1 | Oct 8, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $13 → $9 | $0.72 | +1,151.74% | 3 | Aug 3, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $14 | $3.60 | +288.89% | 1 | Jul 13, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $9 → $11 | $0.49 | +2,124.92% | 7 | May 4, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $8.5 | $3.05 | +179.15% | 1 | Mar 23, 2020 |
Evogene
Sep 12, 2022
Maintains: Buy
Price Target: $100 → $80
Current: $1.65
Upside: +4,748.48%
DarioHealth
Aug 18, 2022
Maintains: Buy
Price Target: $20 → $15
Current: $0.78
Upside: +1,823.08%
VolitionRx
Aug 15, 2022
Maintains: Buy
Price Target: $9 → $6
Current: $0.81
Upside: +640.74%
Immunic
Aug 8, 2022
Maintains: Buy
Price Target: $40 → $35
Current: $1.07
Upside: +3,171.03%
Stereotaxis
Jul 12, 2022
Initiates: Buy
Price Target: $6
Current: $2.03
Upside: +195.57%
Oramed Pharmaceuticals
May 16, 2022
Maintains: Buy
Price Target: $35 → $30
Current: $2.26
Upside: +1,227.43%
Trevi Therapeutics
Mar 29, 2022
Initiates: Buy
Price Target: $10
Current: $2.77
Upside: +261.01%
MediWound
Mar 21, 2022
Maintains: Buy
Price Target: $63 → $49
Current: $16.78
Upside: +192.01%
Enveric Biosciences
Mar 8, 2022
Downgrades: Hold
Price Target: $350 → $10
Current: $0.35
Upside: +2,757.96%
Cingulate
Jan 11, 2022
Initiates: Buy
Price Target: $2,160
Current: $4.48
Upside: +48,114.29%
Dec 7, 2021
Initiates: Buy
Price Target: $30
Current: $1.64
Upside: +1,729.27%
Nov 15, 2021
Maintains: Buy
Price Target: $750 → $600
Current: $0.75
Upside: +79,454.49%
Nov 1, 2021
Maintains: Buy
Price Target: $9 → $10
Current: $1.32
Upside: +657.58%
Sep 22, 2021
Maintains: Buy
Price Target: $180 → $160
Current: $15.12
Upside: +958.20%
Sep 9, 2021
Maintains: Buy
Price Target: $60 → $56
Current: $30.02
Upside: +86.54%
Aug 17, 2021
Maintains: Buy
Price Target: $26 → $27
Current: $1.59
Upside: +1,598.11%
Jun 7, 2021
Maintains: Buy
Price Target: $40 → $35
Current: $1.18
Upside: +2,866.10%
Mar 22, 2021
Initiates: Buy
Price Target: $12
Current: $1.55
Upside: +674.19%
Jan 26, 2021
Initiates: Buy
Price Target: $75
Current: $12.85
Upside: +483.66%
Oct 19, 2020
Maintains: Buy
Price Target: $13 → $11
Current: $0.32
Upside: +3,291.92%
Oct 8, 2020
Initiates: Buy
Price Target: $180
Current: $2.61
Upside: +6,796.55%
Aug 3, 2020
Maintains: Buy
Price Target: $13 → $9
Current: $0.72
Upside: +1,151.74%
Jul 13, 2020
Initiates: Buy
Price Target: $14
Current: $3.60
Upside: +288.89%
May 4, 2020
Maintains: Buy
Price Target: $9 → $11
Current: $0.49
Upside: +2,124.92%
Mar 23, 2020
Initiates: Buy
Price Target: $8.5
Current: $3.05
Upside: +179.15%